Next Article in Journal
Evidence Based Improvements in Clinical Pharmacy Clerkship Program in Undergraduate Pharmacy Education: The Evidence Based Improvement (EBI) Initiative
Next Article in Special Issue
Antimicrobial Renal Injury in a Pediatric Intensive Care Unit: β-Lactams vs. Vancomycin
Previous Article in Journal
Evaluation of the Impact of a Physical Assessment Course on the Practice of Institutional Pharmacists
Article Menu

Export Article

Open AccessConcept Paper
Pharmacy 2014, 2(4), 260-269;

Optimizing Effectiveness in Electronic Prescriptions for Pediatric Outpatients: A Call for Responsive Action

Provincial Pharmacy Services, Alberta Health Services, Edmonton, AB T5H 3V9, Canada
Nova Southeastern University College of Pharmacy, Fort Lauderdale, FL 33328, USA
Department of Pediatrics at Vassar Brothers Medical Center, Poughkeepsie, NY 12601, USA
Department of Pharmacy at Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN 37232, USA
Alberta Health Services and Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 1Z1, Canada
College of Pharmacy, University of Oklahoma, Oklahoma City, OK 73126, USA
Author to whom correspondence should be addressed.
Received: 15 August 2014 / Revised: 9 September 2014 / Accepted: 9 September 2014 / Published: 30 September 2014
(This article belongs to the Special Issue Pharmacy Paediatrics)
Full-Text   |   PDF [173 KB, uploaded 30 September 2014]   |  


A pediatric compounded non-sterile products repository (pCNP) to optimize the effectiveness and safety of “off-label” use of compounded pharmacotherapy through complete transmission of electronic prescriptions across the continuum of care is described. The advent of electronic prescribing has the potential to refocus and resolve long-standing issues of prescription therapy for pediatric patients related to formulation, indication, dosing, and outcomes follow-up, among others. This white paper describes the architecture and function of the pCNP repository. Further, it calls on professional societies, health information technology (HIT) and pharmaceutical industries, universities, and government to create a safer pediatric pharmacotherapy system across the continuum of care. This system would include pCNPs within the existing federal and corporate database structures for medical language, and integrates advanced system safety features as requirements for prescribing, compounding, and dispensing non-mass produced prescription therapies for children. View Full-Text
Keywords: pediatrics; electronic prescriptions; compounded non-sterile products; repository pediatrics; electronic prescriptions; compounded non-sterile products; repository

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

II, R.H.P.; Benavides, S.; Malak, J.T.; Potts, A.L.; Guirguis, M.; Hagemann, T. Optimizing Effectiveness in Electronic Prescriptions for Pediatric Outpatients: A Call for Responsive Action. Pharmacy 2014, 2, 260-269.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Pharmacy EISSN 2226-4787 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top